Comparison of IONM Between Remimazolam and Propofol

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
Ossification Posterior Longitudinal LigamentCervical Spondylotic Myelopathy
Interventions
DRUG

Arm I (Propofol)

Propofol group will be inducted and maintained total intravenous anesthesia with propofol 2% and remifentanil under Shinider and Minto target controlled infusion (TCI) model, respevtively.

DRUG

Arm II (Remimazolam)

Remimazolam group started total intravenous anesthesia with remiamazolam at 6 mg/kg/h at the time of anesthesia induction, and maintained at 0.5-1.5 mg/kg/h.

Trial Locations (1)

Unknown

GangnamSeverance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT04968054 - Comparison of IONM Between Remimazolam and Propofol | Biotech Hunter | Biotech Hunter